Clinical Trial Update: Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial evaluating 5 mg vortioxetine (Lu AA21004) for the acute treatment of major depressive disorder in elderly patients.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18